Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06845189 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Role of Modified Robbery Exercises on Scapular Dyskinesis in Frozen Shoulder

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed Show 4 more changesShow less
    • Enrollment target: estimated 63 to confirmed 64
    • Eligibility criteria expanded, about 20 words
    • Study description revised
    • Site details revised
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  4. Minor Re-verified, no change to tracked fieldsv2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study aims to find out the role of the modified robbery exercises in the management of scapular dyskinesia in patients with frozen shoulders. This double-blind randomized clinical study will be conducted at approved study center in Lahore Pakistan in line with the ethical principles stated in Declaration of Helsinki. Pain, muscle Activation, ROM, scapular dyskinesia, muscle strength, functional limitation and participants' wellbeing will be recorded at baseline, after week three, and after week six in both intervention and control groups.
Trial Details
NCT Number NCT06845189
Lead Sponsor CMH Lahore Medical College and Institute of Dentistry
Collaborators: University of Lahore
Conditions
(from sponsor)
Frozen Shoulder
Related terms Bursitis
Enrollment 64 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov